# DSC-MRI With Ferumoxytol and DCE-MRI With Gadolinium in Imaging Vascular Properties in Younger Patients With Brain Tumors

> **NCT00978562** · EARLY_PHASE1 · COMPLETED · sponsor: **OHSU Knight Cancer Institute** · enrollment: 14 (actual)

## Conditions studied

- Childhood Brain Neoplasm
- Recurrent Childhood Brain Neoplasm

## Interventions

- **PROCEDURE:** Dynamic Contrast-Enhanced Magnetic Resonance Imaging
- **PROCEDURE:** Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging
- **DRUG:** Ferumoxytol Non-Stoichiometric Magnetite
- **DRUG:** Gadolinium

## Key facts

- **NCT ID:** NCT00978562
- **Lead sponsor:** OHSU Knight Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2015-12
- **Final completion:** 2018-12
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2022-08-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00978562

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00978562, "DSC-MRI With Ferumoxytol and DCE-MRI With Gadolinium in Imaging Vascular Properties in Younger Patients With Brain Tumors". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00978562. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*